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ABSTRACTSBackground: NICE recommends that patients undergoing endoscopy
should cease treatment with a PPI or H2 receptor antagonist for
a minimum of 2 weeks prior to endoscopy to prevent false negative tests.
Aim: To determine the extent to which these NICE guidelines are being
followed in our Trust.
Method: This study analysed data obtained from questionnaires ﬁlled in
by endoscopists at a district general hospital between October, 2010 and
January, 2011.
Results: 67 questionnaire's were analysed. Median patient age was 80
years (male 48%, female 46%). Of the referrals analysed 62.7% were
requested as a 2 week wait[s1] . Of this 2 week wait group, over 4 in 10
patients had been taking a PPI at referral. 24% of those patients on a PPI did
not stop their PPI 2 weeks before endoscopy (of this group, a thirdwere not
verbally advised to stop PPI prior to endoscopy and 46% received the
endoscopy information leaﬂet less than 2 weeks before endoscopy)
Conclusions: Lack of patient information may lead to the need for repeat
procedures and potentially false negative endoscopies. This study high-
lights the importance of giving information leaﬂets during the consulta-
tion and verbally reinforcing the information.
0073: COMPLICATIONS OF LAPAROSCOPIC ADJUSTABLE GASTRIC
BANDING (LAGB) PERFORMED BY ONE SURGEON OVER A 10-YEAR
PERIOD
Corinne Owers, Sophy Rymaruk, Roger Ackroyd. Shefﬁeld Teaching
Hospitals, Shefﬁeld, South Yorkshire, UK
Background: Between November 2001 and September 2011, 1100 lapa-
roscopic adjustable gastric banding operations (LAGB's) were performed
by one surgeon. Our study examined the long-term complication rate.
Methods: All available medical notes (1079 patients) were reviewed.
Results: Mean weight was 120 kg, BMI 43.3. After 10 years of follow-up,
complications occurred in 347 patients. 143 patients experienced band
slippage; re-operation was required in half of these cases. 82 patients had
their band removed due to complications, slippage in 60, erosion in 17 and
band intolerance in 5. 136 patients experienced port problems; 37 were
ﬂipped on clinical or radiological ﬁlls, 17 patients had port infection. 50
ports required repositioning due to discomfort or difﬁculty with clinical
ﬁlls; 16 were removed or replaced, including 5 for cutaneous erosion. 4
patients required other procedures to deal with intra-operative compli-
cations. 18 patients had a concurrent procedure. The only post-operative
death was due to biliary peritonitis in a patient who had undergone
simultaneous cholecystectomy.
Conclusion: Complication rates reﬂect the literature. Slippage rate may
appear higher in our patients, but this is because most patients undergo
radiological band ﬁlls hence many non-symptomatic slippages are detec-
ted. Only half of our slippages were clinically apparent or needed any
intervention.
0138: POST-OPERATIVE RECOVERY FROM CHOLECYSTECTOMY AT
A DISTRICT GENERAL HOSPITAL
Andrew Hannah, Jake Foster, Michael Terry. Isle of Wight NHS Trust, Isle of
Wight, UK
Laparoscopic cholecystectomy is one of the most common general surgical
operations; however the majority of patients undergoing this procedure
receive no routine surgical follow-up. Descriptions of the recovery period
and quoted rates of potential complications when counselling patients for
this procedure are hence potentially inaccurate.
We sent a postal questionnaire to all patients who had undergone a chole-
cystectomy at our institution over a 6month period (median 5months post-
op) in order to investigate patients’ recovery from this procedure.
60% of 100 patients contacted returned the questionnaire. Median time to
return to work and driving was 2 weeks. 48% of patients reported having
a post-operative problem that they consulted their GP or A&E regarding: 50%
of thesewereprescribed antibiotics. Reported complications includedLRTI in
3.5%of responders, andsurgical site infection in22%.Asinglepatient required
re-operation, and 6 patients (10%) reported re-admission to hospital.
Little information speciﬁc to our unit has previously been available to aid
in counselling patients undergoing cholecystectomy. Rates of surgical site
infection and post-operative antibiotic requirements were much higher
than our estimates. Knowledge of this may have an impact upon theway in
which we practice and perform this operation in the future.0183: CENTRALISATION OF UPPER GI CANCER SERVICES – IS THE HUB
BETTER THAN THE SPOKE?
Simon Monkhouse, Jana Torres-Grau, Daniel Bawden, Claire Ross, Richard
Krysztopik. Royal United Hospital, Bath, UK
Aims: To assess whether patients diagnosed with oesophageal or gastric
cancer at a local district general hospital (the "spoke") have a similar
temporal pathway through the decision making and treatment process
compared to those patients presenting at the centralised, tertiary hospital
(the "hub").
Methods: Between April 2010 and April 2011, patients with a new diag-
nosis of oesophago-gastric cancer from both the hub and spoke hospitals
were included. Data regarding diagnosis, time from diagnosis to multi-
disciplinary (MDM) discussion and time from MDM decision to ﬁrst
treatment were all recorded and prospectively analysed.
Results: There was a statistically signiﬁcant increase in the time from
diagnosis to MDM discussion at the spoke hospital compared to the hub.
(13.3 days vs.+ 25.67 days; P¼0.001). However, time to ﬁrst was signiﬁ-
cantly increased in the hub hospital compared to the spoke (43.4 days vs
25.5 days; P¼0.023).
Conclusions:Witholding its limitations, this study is the ﬁrst of its kind to
show that there is a disparity in the management pathways of patients
who ﬁrst present to a regional hospital rather than the tertiary centre.
Patients at the spoke hospital have a longer lead time into MDM but non-
operative treatment appears to be delivered more quickly locally.
0203: OUTCOMES AT ONE YEAR FOLLOWING LAPAROSCOPIC SLEEVE
GASTRECTOMY IN WALES
Andrew J. Beamish, Jessica J. Foster, Nia Eyre, William Beasley, Scott
Caplin, John Baxter, Jonathan Barry. Welsh Institute of Metabolic and
Obesity Surgery, Morriston Hospital, Swansea, Wales, UK
Aim: Seven of the UK's ten worst areas for morbid obesity occur within
Wales and bariatric surgery is the only proven treatment strategy. This
study aimed to compare percentage excess weight loss (%EWL) and
comorbidity resolution following laparoscopic sleeve gastrectomy (LSG)
against UK National Bariatric Surgery Registry 2010 (NBSR) ﬁgures.
Methods: Retrospective analysis was performed on patients undergoing
LSG at a single centre. Weight and Body Mass Indices (BMIs) were
measured pre-operatively, at 3-6months (n¼28) and at 12months (n¼20).
Obesity-related comorbidities of type-II diabetes mellitus (T2DM), hyper-
tension and obstructive sleep apnoea (OSA) were recorded preoperatively
and at 12 months.
Results: Twenty-eight patients (median age 45.5 years [17-63yrs],
m:f¼7:21) were studied. At 3-6 months median %EWL was 28.0% (9.2–
67.2%); median BMI reduced from 46.5kgm-2 to 37.8kgm-2. At 12 months
(20 patients), median %EWL was 55.7% (24.4-88.0%); median BMI reduced
from 45.0kgm-2 to 32.3kgm-2. At 12 months, 100% of patients (7 pts) with
T2DM, 100% (6 pts) with hypertension and 80% (5 pts) with OSA demon-
strated improvement or complete resolution of comorbidity.
Conclusion: Percentage EWL and comorbidity resolution at twelve
months compare favourably with those of the NBSR (%EWL¼56% vs. 54%;
T2DM resolution¼100% vs. 50%) after LSG.
0231: A 10 YEAR RETROSPECTIVE ANALYSIS OF OUTCOMES FOLLOWING
PERFORATED GASTRIC OR DUODENAL ULCER
Kathryn Lynes, Sobana Vicknesvaran, Ali Al-Temimi, Kislaya Thakur. Queen
Elizabeth Hospital; South London Healthcare NHS Trust, Woolwich,
London, UK
Aim: Despite improved medical management for peptic ulcer disease,
incidence of perforated ulcer remains unchanged, resulting in high
mortality and morbidity. This study aims to establish outcomes following
surgery for perforated ulcer and identify factors predicting mortality and
morbidity.
Method: Records of 48 patients undergoing surgery for perforated peptic
ulcer from 2001 to 2010 were retrospectively reviewed. Factors signiﬁ-
cantly increasing mortality and morbidity were determined with multi-
variate logistic regression. Factors analysed included: age; ASA grade; pre-
operative shock; co-morbidities and delayed presentation.
Results: There were 36 male and 12 female patients with mean age of 55
(range 20-89). 44 patients had a duodenal perforation. Only 2 perforations
Abstracts / International Journal of Surgery 10 (2012) S53–S109S92
ABSTRACTSwere repaired laparoscopically. ASA grade and pre-operative shock inde-
pendently predictedmortality (p<0.01). ASA grade predictedmorbidity (p
<0.01). Patients with Boey Score of 0, 1, 2 and 3 had 0, 6, 55 and 100%
mortality respectively.
Conclusions: Our 30-day mortality of 14.6% compares to published ﬁgures
of 4-31%. Morbidity of 50% was higher than expected which may be due to
deﬁnition or case mix. The development of guidelines for managing
perforated ulcer would permit comparison of outcomes between centres.
Future directions for improving care include management of sepsis and
use of laparoscopic surgery.
0482: DOES A RELATIONSHIP EXIST BETWEEN BLOOD GROUPS AND
GASTRO-OESOPHAGEAL JUNCTIONAL TUMOURS?
Rachel Barnes, Rhiannon Bowen, Timothy Havard, Xavier Escofet. Royal
Glamorgan Hospital, Llantrisant, UK
Aims: Many studies have been carried out to investigate the association of
blood group antigens and disease. Cancers in general appear to be associated
with group A and to a lesser extent group B. This study aimed to establish
whether there is a positive association between inherited blood group anti-
gens and the development of Gastro-oesophageal junctional (GOJ) tumours.
Methods: A retrospective analysis of a prospectively maintained database
to identify all patients with GOJ tumours from 2000-2010. The blood
groups and data on other risk factors were collected and compared with
information from theWelsh Blood Service on the relevant catchment area.
Statistical analysis was performed using the Chi squared test.
Results: 210 patients were diagnosed with GOJ tumour (79% male). Age
range 31- 89 years (mean 68 years). All patients were Caucasian. The
distribution of blood groups within the patient cohort was comparable to
that of the general population within the catchment area (p¼ 0.062- 0.9).
Conclusion: There appears to be no association between blood groups and
the development of gastro-oesophageal cancer. Larger scale studies will be
required.
0530: FAST TRACK UPPER GASTROINTESTINAL SURGERY – A
SYSTEMATIC REVIEW
Dilan Dabare, Vanash Patel, Emmanouil Zacharakis. Queen Alexandra
Hospital, Southsea, Portsmouth, UK
Aims: The aim of this systematic review was to evaluate the feasibility of
fast track surgery in upper gastrointestinal surgery.
Methods: A systematic review was performed by searching EMBASE, Med-
line, PsycINFO and Cochrane Library. The search strategy included the
keywords: fast track, enhanced recovery and multimodal rehabilitation/
optimization/perioperative care. We included all original studies and classi-
ﬁed them according to the 17 fast-track interventions proposed by the
Enhanced Recovery After Surgery Group. The primary endpoints were
median length of hospital stay (LOS), readmissions, morbidity andmortality.
Results: 13 studies reporting on a total of 1621 patients were found: 2
randomised control trials and a case-series in gastric surgery; 2 case-
control studies and a case-series in hepatic surgery; 2 case-series in
oesophageal surgery; 2 case-control studies and 3 case-series in pancreatic
surgery. The highest number of interventions implemented in gastric,
hepatic, oesophageal and pancreatic surgery were 13, 15, 5 and 12
respectively. In all types of upper gastrointestinal surgery studies
demonstrated a reduction in median length of stay ranging from 2-6 days,
without an increase in readmission rates, morbidity and mortality.
Conclusions: Initial studies show that fast-track surgery is feasible and
may reduce length of stay. However, high quality studies are required.
0552: AN AUDIT OF THE USE OF PET-CT AND FITNESS ASSESSMENT IN
PATIENTS WITH OESOPHAGO-GASTRIC CANCER
Emily Hotton, Srikant Ganesh, Natalie Blencowe, Robert Whistance, Sean
Strong, Jane Blazeby. University of Bristol, Bristol, UK
Aim: Accurate staging in oesophago-gastric (OG) cancer is essential for
patients considered for radical treatment. National guidelines recommend
that Positron Emission Tomography Computed Tomography (PET-CT) be
performed in all OG cancer patients without CT evidence of metastatic
disease and who are deemed ﬁt for curative treatment. This study assessed
adherence of the upper gastrointestinal (UGI) cancer multi-disciplinary
team (MDT) to this audit standard.Methods: A retrospective review of prospectively kept MDT records was
performed for consecutive patients with OG cancer discussed at the central
MDT between July 2008 and July 2010. Data collection included investi-
gations performed, treatment outcomes and patient ﬁtness.
Results: 102 MDT meetings discussed 460 patients with OG cancer of
whom 241 were primarily considered for curative treatment. Of these, 3
patients did not undergo PET-CT and reasons for this were unknown. 24
patients (10.0%) were subsequently considered unﬁt for curative treat-
ment. The audit target was met in 214 patients (88.7%).
Conclusion: Adherence to national PET-CT guidelines by the UGI MDT was
good. Unnecssary PET-CT staging was performed in a number of patients
ultimately deemed unﬁt for curative treatment. Early ﬁtness assessment in
the treatment pathwaycould improve compliancewithnational guidelines.
0553: AN AUDIT OF STAGING INVESTIGATIONS FOR PATIENTS
UNDERGOING CURATIVE TREATMENT IN OESOPHAGO-GASTRIC
CANCER
Srikant Ganesh, Emily Hotton, Natalie Blencowe, Robert Whistance, Jane
Blazeby, Sean Strong. University of Bristol, Bristol, UK
Aim: Current guidelines recommend the use of Positron Emission
Tomography Computed Tomography (PET-CT) in all ﬁt patients with
oesophago-gastric cancer (OGC), as part of the staging process. This study
assessed investigations performed on recommendation of the upper
gastrointestinal (UGI) cancer multi-disciplinary team (MDT) in patients
scheduled for curative treatment. Unnecessary investigations were
deﬁned as those undertaken in patients ultimately deemed unﬁt for
curative treatment.
Method: A review of MDT records was performed for consecutive patients
with OG cancer discussed between 2008 and 2010. Details of all staging
investigations and ﬁnal management decisions were evaluated.
Results: 460 OGC patients were discussed. 241 were initially considered
for curative treatment of which 24 were subsequently considered unﬁt. In
these patients, 31 unnecessary investigations were performed including 18
endoscopic ultrasounds (75.0%), 4 second CT scans (16.7%), 5 staging
laparoscopies (20.8%) and 4 additional investigations (16.7%).
Conclusion: Unnecessary staging investigations could have been avoided
in approximately 10% of patients with cost saving implications.
0581: COMPLICATIONS AFTER BARIATRIC SURGERY
Michail Chatzikonstantinou, Tereza Remesova, Cemal Kavasogullari, Pratik
Suﬁ. Whittington Hospital NHS trust, London, UK
Aim/Objective: To audit outcomes of bariatric surgery at North London
Obesity Surgery Service (NLOSS). Participants: All patients who underwent
elective bariatric surgery at NLOSS between January 2007 and October
2011
Main Outcome Measures. Mortality, overall un-planned readmission,
median length of stay in hospital according to type of operations, gender
and age.
Methods and data collection: A retrospective analysis of patient
outcomes was performed using 4-year discharge data. Of 463 patients, 313
were Laparoscopic Roux-en Y Gastric Bypass (67,6%), 129 Gastric Band
(57,8%) and 21 sleeve gastrectomy (5,4%). The patients for every procedure
were divided into three age groups, 17-40 years, 41-60 and older than 60
years old. We examined these three procedures separately and compared
mortality rates, median length of admission, and readmissions by age and
gender.
Results: The overall mortality rate was 0.86. The median length of stay for
gastric bypass and band was 4 days (0-34) and 2 (0-7) respectively and the
unplanned 28 day readmission rate was 10.8% and 8.7% respectively.
Conclusions:Our statistical results were similar to international guide-
lines, with no signiﬁcant difference with literature references.
0758: REMISSION OF TYPE 2 DIABETES FOLLOWING ROUX-EN-Y
GASTRIC BYPASS ACCORDING TO NEW GUIDELINES
Haritharan Nageswaran, Martin Nnaji, Dimitri J. Pournaras, David
Mahon, Richard Welbourn. Taunton and Somerset Foundation Trust,
Taunton, Somerset, UK
Aim: Bariatric surgery is considered a long-term solution to the rising
incidence of Type 2 Diabetes (T2DM) secondary to obesity, with a meta-
